Next Generation Sequencing Improves the Accuracy of KRAS Mutation Analysis in Endoscopic Ultrasound Fine Needle Aspiration Pancreatic Lesions

被引:56
作者
de Biase, Dario [1 ,2 ]
Visani, Michela [2 ]
Baccarini, Paola [1 ]
Polifemo, Anna Maria [3 ]
Maimone, Antonella [4 ]
Fornelli, Adele [5 ]
Giuliani, Adriana [6 ]
Zanini, Nicola [7 ]
Fabbri, Carlo [3 ]
Pession, Annalisa [2 ]
Tallini, Giovanni [1 ]
机构
[1] Univ Bologna, Bellaria Hosp, Anat Pathol Unit, Dept Med DIMES, Bologna, Italy
[2] Univ Bologna, Dept Pharmacol & Biotechnol FaBiT, Bologna, Italy
[3] Bellaria Hosp, Azienda Unita Sanit Locale Bologna, Gastroenterol Unit, Bologna, Italy
[4] Univ Ferrara, Sch Gastroenterol, I-44100 Ferrara, Italy
[5] Maggiore Hosp, Azienda Unita Sanit Locale Bologna, Anat Pathol Unit, Bologna, Italy
[6] Indiana Univ, Bloomington, IN USA
[7] Maggiore Hosp, Azienda Unita Sanit Locale Bologna, Unit Gen Surg, Bologna, Italy
关键词
K-RAS GENE; CANCER; DIAGNOSIS; NEOPLASMS; UTILITY; CLASSIFICATION; HYBRIDIZATION; TISSUE; TUMORS; BRAF;
D O I
10.1371/journal.pone.0087651
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The use of endoscopic ultrasonography has allowed for improved detection and pathologic analysis of fine needle aspirate material for pancreatic lesion diagnosis. The molecular analysis of KRAS has further improved the clinical sensitivity of preoperative analysis. For this reason, the use of highly analytical sensitive and specific molecular tests in the analysis of material from fine needle aspirate specimens has become of great importance. In the present study, 60 specimens from endoscopic ultrasonography fine needle aspirate were analyzed for KRAS exon 2 and exon 3 mutations, using three different techniques: Sanger sequencing, allele specific locked nucleic acid PCR and Next Generation sequencing (454 GS-Junior, Roche). Moreover, KRAS was also tested in wild-type samples, starting from DNA obtained from cytological smears after pathological evaluation. Sanger sequencing showed a clinical sensitivity for the detection of the KRAS mutation of 42.1%, allele specific locked nucleic acid of 52.8% and Next Generation of 73.7%. In two wild-type cases the re-sequencing starting from selected material allowed to detect a KRAS mutation, increasing the clinical sensitivity of next generation sequencing to 78.95%. The present study demonstrated that the performance of molecular analysis could be improved by using highly analytical sensitive techniques. The Next Generation Sequencing allowed to increase the clinical sensitivity of the test without decreasing the specificity of the analysis. Moreover we observed that it could be useful to repeat the analysis starting from selectable material, such as cytological smears to avoid false negative results.
引用
收藏
页数:12
相关论文
共 42 条
[1]   454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples [J].
Altimari, Annalisa ;
de Biase, Dario ;
De Maglio, Giovanna ;
Gruppioni, Elisa ;
Capizzi, Elisa ;
Degiovanni, Alessio ;
D'Errico, Antonia ;
Pession, Annalisa ;
Pizzolitto, Stefano ;
Fiorentino, Michelangelo ;
Tallini, Giovanni .
ONCOTARGETS AND THERAPY, 2013, 6 :1057-1064
[2]   Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation [J].
Arvanitakis, M ;
Van Laethem, JL ;
Parma, J ;
De Maertelaer, V ;
Delhaye, M ;
Devière, J .
ENDOSCOPY, 2004, 36 (06) :535-542
[3]   Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis [J].
Bournet, B. ;
Souque, A. ;
Senesse, P. ;
Assenat, E. ;
Barthet, M. ;
Lesavre, N. ;
Aubert, A. ;
O'Toole, D. ;
Hammel, P. ;
Levy, P. ;
Ruszniewski, P. ;
Bouisson, M. ;
Escourrou, J. ;
Cordelier, P. ;
Buscail, L. .
ENDOSCOPY, 2009, 41 (06) :552-557
[4]   Effective Assessment of egfr Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing [J].
Buttitta, Fiamma ;
Felicioni, Lara ;
Del Grammastro, Maela ;
Filice, Giampaolo ;
Di Lorito, Alessia ;
Malatesta, Sara ;
Viola, Patrizia ;
Centi, Irene ;
D'Antuono, Tommaso ;
Zappacosta, Roberta ;
Rosini, Sandra ;
Cuccurullo, Franco ;
Marchetti, Antonio .
CLINICAL CANCER RESEARCH, 2013, 19 (03) :691-698
[5]  
Chhieng D, 2007, PANCREATIC CYTOPATHO
[6]   Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation [J].
Corbo, Vincenzo ;
Tortora, Giampaolo ;
Scarpa, Aldo .
CURRENT DRUG TARGETS, 2012, 13 (06) :744-752
[7]   Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes [J].
Däbritz, J ;
Hänfler, J ;
Preston, R ;
Stieler, J ;
Oettle, H .
BRITISH JOURNAL OF CANCER, 2005, 92 (02) :405-412
[8]  
De Angelis C, 2007, J PANCREAS, V8, P85
[9]  
Dillon DA, 2000, CANCER J, V6, P294
[10]  
Fuccio L, 2013, GASTROINTEST ENDOSC